Search results
Results From The WOW.Com Content Network
Globally testicular cancer resulted in 8,300 deaths in 2013 up from 7,000 deaths in 1990. [9] Testicular cancer has the highest prevalence in the U.S. and Europe, and is uncommon in Asia and Africa. [67] Worldwide incidence has doubled since the 1960s, [68] with the highest rates of prevalence in Scandinavia, Germany, and New Zealand. [citation ...
This is a list of countries by cancer frequency, as measured by the number of new cancer cases per 100,000 population among countries, based on the 2018 GLOBOCAN statistics and including all cancer types (some earlier statistics excluded non-melanoma skin cancer).
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
Previous ACS research had shown that rates of 11 cancers, including pancreatic, colorectal, kidney, uterine and testicular cancer, had been increasing among young adults. The new study added eight ...
The cancer rate among females younger than 50 years is now 82% higher than in males, an increase from 51% in 2002. In addition, among people younger than 65 years, lung cancer incidence is higher ...
In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8]
PT-DLBCL is by far the most common form of testicular cancer in men >60 years of age. [2] It usually develops in this age group (median age ~65 years old, range 10–96 years) and presents as a painless testicular mass or swelling in one testis or, in ~6% of cases, both testes: [1] PT-DLBCL is the most common testicular cancer to present with disease in both testicles. [8]
For example, adolescents and young adults with acute lymphoblastic leukemia (ALL) may have better outcomes if they are treated with pediatric treatment protocols rather than adult treatment protocols. The 5-year survival rates for 15- to 19-year-olds with ALL has risen to 74% as of 2007–2013, from survival rates of around 50% in the early 1990s.